These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22495163)

  • 1. Statins and coronary artery disease: clinical evidence and future perspective.
    Biasucci LM; Stefanelli A; Biasillo G
    Minerva Cardioangiol; 2012 Apr; 60(2):147-56. PubMed ID: 22495163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent clinical studies of the effects of lipid-modifying therapies.
    Gotto AM; Moon JE
    Am J Cardiol; 2012 Jul; 110(1 Suppl):15A-26A. PubMed ID: 22697388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Can statins slow the process of vascular calcification? Possibilities of lipid-lowering therapy and pleiotropic effect by statin treatment].
    Iijima K; Ouchi Y
    Clin Calcium; 2010 Nov; 20(11):1719-28. PubMed ID: 21037393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy.
    Wiviott SD; Cannon CP
    Curr Opin Lipidol; 2006 Dec; 17(6):626-30. PubMed ID: 17095906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intensive lipid lowering on coronary atheroma and clinical outcome.
    Houslay ES; Sarma J; Uren NG
    Heart; 2007 Feb; 93(2):149-51. PubMed ID: 17035507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial clouds use of niacin with a statin.
    Harv Heart Lett; 2011 Aug; 21(12):2. PubMed ID: 21991606
    [No Abstract]   [Full Text] [Related]  

  • 7. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stroke prevention by statins].
    Sawada N; Itoh H; Nakao K
    Nihon Rinsho; 2002 May; 60(5):993-1001. PubMed ID: 12030004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coronary heart disease prevention. Are there differences in cholesterol synthesis inhibitors?].
    Müller-Wieland D; Faust M; Schleifenbaum T; Krone W
    MMW Fortschr Med; 2000 Jul; 142(30):26-8. PubMed ID: 10955015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of statins in heart failure.
    Gullestad L; Oie E; Ueland T; Yndestad A; Aukrust P
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():35-40. PubMed ID: 18001320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
    Fabbri G; Maggioni AP
    Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin therapy--Part II: Clinical considerations for cardiovascular disease.
    Sadowitz B; Seymour K; Costanza MJ; Gahtan V
    Vasc Endovascular Surg; 2010 Aug; 44(6):421-33. PubMed ID: 20547576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Statins in coronary patients: a solved issue?].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 2008 Feb; 57 Suppl 1():16-23. PubMed ID: 18472029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of statins beyond lipid lowering: potential for clinical benefits.
    Almuti K; Rimawi R; Spevack D; Ostfeld RJ
    Int J Cardiol; 2006 Apr; 109(1):7-15. PubMed ID: 16054715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.
    Ong HT
    QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
    Marzilli M
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stents and statins: history, clinical outcomes and mechanisms.
    Nair PK; Mulukutla SR; Marroquin OC
    Expert Rev Cardiovasc Ther; 2010 Sep; 8(9):1283-95. PubMed ID: 20828351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.